Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
06/2003
06/19/2003WO2002060434A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
06/19/2003US20030114691 Synthetic methods for preparing procyanidin oligomers
06/19/2003US20030114689 For use as intermediates in preparation of pyrethroids
06/19/2003US20030114485 Killing drug resistant cancer cells; controlling cell differentiation
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114440 Compositions and methods of treatment for conditions responsive to testosterone elevation
06/19/2003US20030113665 Optical data medium containing, in the information layer, a dye as a light-absorbing compound
06/19/2003US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health
06/19/2003US20030113290 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/17/2003US6579903 Klainetins and their derivatives, method for their preparation and use thereof
06/17/2003US6579863 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
06/17/2003US6579534 Mixture of soy protein and isoflavone
06/12/2003WO2003048151A1 Method for preparing chiral amines
06/12/2003WO2003048101A1 Induction of apoptosis in cancer cells
06/12/2003WO2003024183A3 Wortmannin analogs and methods of using same
06/12/2003US20030109721 Oxidation of mestanolone; hydroxylation; reduction
06/12/2003US20030109718 Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
06/12/2003US20030109705 Novel cyanoenamines useful as ligands for modulating gene expression in plants or animals
06/12/2003US20030109576 Tartrate salts of (r) -3-n,n- dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1- benzopyran-5-carboxamide
06/12/2003US20030109574 Process for producing 4-substituted benzopyran derivatives
06/12/2003US20030109573 A stent comprised of a stent body coated with a compound of the following formula:with hetero compounds
06/12/2003US20030109572 Wortmannin analogs and methods of using same
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109504 Inhibit metabotropic glutamate receptor activity, or activation, for use in the treatment of movement disorders associated with a poverty of movement (e.g. Parkinson's disease). The compounds are particularly useful when used in
06/12/2003US20030109462 Plants and insecticidal compositions comprising the naringenin derivatives as active components.
06/12/2003CA2468745A1 Induction of apoptosis in cancer cells
06/12/2003CA2437251A1 Method for preparing chiral amines
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317438A1 Chromanone derivatives
06/11/2003EP1317437A2 Synthesis of 4-alpha-arylepicatechins
06/11/2003EP1042289A4 Indole]naphthopyrans, preparation, compositions and (co)polymer matrices containing them, synthesis intermediates
06/11/2003EP0968203B1 Photoactive coumarin sulfonate compounds
06/11/2003CN1423635A Nitrogenous compounds and antiviral drugs containing the same
06/11/2003CN1423557A Intracorporeal medicaments for photodynamic treatment of disease
06/11/2003CN1422856A Soybean isoflavone, soybean saponin and soybean oligosaccharide extraction method
06/11/2003CN1422855A Industrialized production method of soybean isoflavone using soybean cake
06/10/2003US6576771 Pesticides, herbicides and fungicides
06/10/2003US6576660 Methods and compositions for regulation of 5-α-reductase activity
06/10/2003US6576595 Potent activity
06/10/2003US6576275 Process for extracting polyphenolic antioxidants from purine-containing plants
06/10/2003US6576271 Method for inhibiting inflammation using bioflavonoids
06/10/2003US6576192 Fluoroionophores and their use in optical ion sensors
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/05/2003WO2003045328A2 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003US20030105342 Process for stereoselective synthesis of 2-hydroxymethyl chromans
06/05/2003US20030105340 Reacting a isochroman-1,3-dione with a carbonyl compound whose carbonyl group is substituted with an acyl activating group, in the presence of a base and a solvent; use making anticancer agents for example
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030105030 Method and compositions for regulation of 5-alpha reductase activity
06/05/2003US20030104380 Compositions and methods for labeling oligonucleotides
06/05/2003US20030104084 Process for obtaining solid soy isoflavone -containing products
06/05/2003CA2467664A1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/04/2003EP1315712A1 Intermediates for use in the preparation of vitamin e
06/04/2003EP1315711A1 Method for producing dihydrocoumarin by hydrogenating coumarin
06/04/2003EP1315485A1 Cathartic composition
06/04/2003EP1062217B1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0934296B1 Chroman derivatives
06/04/2003EP0789578B1 Multicatalytic protease inhibitors
06/04/2003CN1421426A New process of preparing tea polyphenol with high catechin content and low caffine content
06/03/2003US6572876 Soy protein, isoflavone and plant sterol coadministered for atherosclerosis prevention
06/03/2003US6572839 Sensitizer for tumor treatment
05/2003
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003044005A1 Cruentaren a and b as pharmaceuticals and agrochemicals
05/30/2003WO2003043619A1 New use for the treatment of gastroesophageal reflux disease
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2003013442A3 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/30/2003CA2466916A1 New use for the treatment of gastroesophageal reflux disease
05/29/2003US20030100775 Synthesis of 4alpha-arylepicatechins
05/29/2003US20030100774 Process for synthesis of 2-yl chroman derivatives
05/29/2003US20030100556 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
05/29/2003US20030100082 Isolation of proanthocyanidins from a flavonoid- producing cell; obtain flavonoid producing cell, culture, ferment proanthocyanidins, extract and fractionate proanthocyanidins
05/29/2003US20030099807 Optical recording medium
05/28/2003EP1314730A1 Reagent for determining singlet oxygen
05/28/2003EP1237885A4 Method for preparing dl-alpha-tocopherol with a high yield and high purity
05/28/2003EP1212313B1 7-carboxy-flavone derivatives, preparation method and therapeutic use
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/28/2003CN1109682C Process for extracting soybean isoflavone and soybean glucoside
05/28/2003CN1109681C Flavone chromium, its producing method and use thereof
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003CA2268438C Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
05/27/2003CA2084961C Tissue protective tocopherol analogs
05/22/2003WO2003042203A1 Chromene compound
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042133A1 Extraction of phenolic antioxidants
05/22/2003WO2003024943A3 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis
05/22/2003WO2002076937A3 Aminobenzopyran derivatives and compositions
05/22/2003US20030097008 Chemical amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
05/22/2003US20030096860 Benzopyran derivative and antiallergic agent
05/22/2003US20030096729 A cyclopenta(B)pyran or chromene lactones; perfumed articles, colognes and perfumed polymers; lactonization, amination, decyclization, imidation, ketalization, cyclization
05/22/2003US20030096192 For application to polycarbonate substrate by spin coating or vapor deposition
05/22/2003US20030096117 Base structure is a chromene(3,2-a)fluorene ring containing spiro-fused rings; photochromic lenses; large fading rate, less color when deteriorated, and excellent light resistance in the photochromic properties
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466514A1 Extraction of phenolic antioxidants
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 242